{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:12:11Z","timestamp":1785787931591,"version":"3.56.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"crossref","award":["600-RMC\/MOHE HICoE CARE-I 5\/3 (01\/2025)"],"award-info":[{"award-number":["600-RMC\/MOHE HICoE CARE-I 5\/3 (01\/2025)"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Newton-Ungku Omar Fund","award":["100-TNCPI\/GOV 16\/6\/2 (002\/2020)-02 and MR\/T 017384\/1"],"award-info":[{"award-number":["100-TNCPI\/GOV 16\/6\/2 (002\/2020)-02 and MR\/T 017384\/1"]}]},{"name":"Malaysia Ministry of Higher Education Long Term Research Grant Scheme","award":["[600-RMI\/LRGS 5\/3 (2\/2011)-2]"],"award-info":[{"award-number":["[600-RMI\/LRGS 5\/3 (2\/2011)-2]"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,27]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>\n                      Homozygous familial hypercholesterolemia (HoFH) is a rare inherited disorder with an extremely elevated level of low-density lipoprotein (LDL) cholesterol (LDL-C) and accelerated premature coronary artery disease (PCAD). It is primarily caused by a single pathogenic variant of the LDL receptor (\n                      <jats:italic toggle=\"yes\">LDLR<\/jats:italic>\n                      ) gene. This report presents 2 rare and unrelated cases of HoFH with compound\n                      <jats:italic toggle=\"yes\">LDLR<\/jats:italic>\n                      mutations. These 2 individuals presented with atypical clinical features and demonstrated variable degrees of hypercholesterolemia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>Case 1 is a 36-year-old Malay woman identified during family cascade screening with a pretreated LDL-C of 8.5 mmol\/L and a strong family history of PCAD. Case 2 is a 58-year-old Indian woman discovered to have a pretreated LDL-C of 5.2 mmol\/L during routine health screening, without a significant family history of hypercholesterolemia or PCAD. Neither patient demonstrated tendon xanthomas or other lipid stigmata.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>\n                      Both patients underwent lipid profiling and targeted next-generation sequencing of FH-related genes (\n                      <jats:italic toggle=\"yes\">LDLR<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">APOB<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">PCSK9<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">ABCG5<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">ABCG8<\/jats:italic>\n                      ). Two novel\n                      <jats:italic toggle=\"yes\">LDLR<\/jats:italic>\n                      variants were identified in exon 18: c.2548-1_2548delGAinsTC (pathogenic) and c.2556_2557insTCAGTCTGG (p.Leu853Serfs*12; likely pathogenic) and classified according to American College of Medical Genetics and Genomics guidelines. Case 1 was homozygous for both variants, while Case 2 was homozygous for the splice-site variant and heterozygous for the frameshift variant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Both patients received guideline-directed lipid-lowering therapy and ongoing cardiovascular risk management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>\n                      Despite biallelic\n                      <jats:italic toggle=\"yes\">LDLR<\/jats:italic>\n                      variants, both patients demonstrated relatively milder hypercholesterolemia and absence of classical HoFH stigmata.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic toggle=\"yes\">LDLR<\/jats:italic>\n                      variants located in exon 18 affecting the cytoplasmic tail domain may be associated with attenuated clinical expression. Recognition of genotype\u2013phenotype variability is crucial for accurate diagnosis, risk stratification, and individualized management of HoFH.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000047768","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T01:00:52Z","timestamp":1772240452000},"page":"e47768","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Variable phenotype associated with compound LDLR gene mutations in familial hypercholesterolemia patients: Case series and clinical implications"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3855-5768","authenticated-orcid":false,"given":"Noor Alicezah","family":"Mohd Kasim","sequence":"first","affiliation":[{"name":"Cardiovascular Advancement and Research Excellence Institute (CARE Institute), Universiti Teknologi MARA, Selangor, Malaysia"},{"name":"Department of Pathology, Faculty of Medicine, Universiti Teknologi MARA, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2387-0087","authenticated-orcid":false,"given":"Yung-An","family":"Chua","sequence":"additional","affiliation":[{"name":"Cardiovascular Advancement and Research Excellence Institute (CARE Institute), Universiti Teknologi MARA, Selangor, Malaysia"},{"name":"Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Universiti Teknologi MARA, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-4839","authenticated-orcid":false,"given":"Siti Hamimah","family":"Sheikh Abdul Kadir","sequence":"additional","affiliation":[{"name":"Cardiovascular Advancement and Research Excellence Institute (CARE Institute), Universiti Teknologi MARA, Selangor, Malaysia"},{"name":"Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Universiti Teknologi MARA, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6117-0087","authenticated-orcid":false,"given":"Alyaa","family":"Al-Khateeb","sequence":"additional","affiliation":[{"name":"Cardiovascular Advancement and Research Excellence Institute (CARE Institute), Universiti Teknologi MARA, Selangor, Malaysia"},{"name":"Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Universiti Teknologi MARA, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5472-4248","authenticated-orcid":false,"given":"Aimi Zafira","family":"Razman","sequence":"additional","affiliation":[{"name":"Cardiovascular Advancement and Research Excellence Institute (CARE Institute), Universiti Teknologi MARA, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3686-771X","authenticated-orcid":false,"given":"Sukma Azureen","family":"Nazli","sequence":"additional","affiliation":[{"name":"Cardiovascular Advancement and Research Excellence Institute (CARE Institute), Universiti Teknologi MARA, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2719-5659","authenticated-orcid":false,"given":"Aisyah","family":"Kamal","sequence":"additional","affiliation":[{"name":"Cardiovascular Advancement and Research Excellence Institute (CARE Institute), Universiti Teknologi MARA, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2100-8040","authenticated-orcid":false,"given":"Johanes Dedi","family":"Kanchau","sequence":"additional","affiliation":[{"name":"Cardiovascular Advancement and Research Excellence Institute (CARE Institute), Universiti Teknologi MARA, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1505-1612","authenticated-orcid":false,"given":"Yeow Siong","family":"Lee","sequence":"additional","affiliation":[{"name":"Selayang Baru Health Clinic, Jln Sungai Tua, Taman Selayang, Batu Caves, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3654-2146","authenticated-orcid":false,"given":"Mohamed Syarif","family":"Mohamed Yassin","sequence":"additional","affiliation":[{"name":"Department of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4909-0644","authenticated-orcid":false,"given":"Nadeem","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Centre of Academic Primary Care, School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5871-405X","authenticated-orcid":false,"given":"Hapizah","family":"Nawawi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Universiti Teknologi MARA, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9517-1413","authenticated-orcid":false,"given":"Anis Safura","family":"Ramli","sequence":"additional","affiliation":[{"name":"Department of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260413","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","article-title":"The LDL receptor.","volume":"29","author":"Goldstein","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R2-20260413","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2213-8587(16)30041-9","article-title":"Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the international atherosclerosis society severe familial hypercholesterolemia panel.","volume":"4","author":"Santos","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R3-20260413","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"R4-20260413","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MOL.0000000000000675","article-title":"Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?","volume":"31","author":"Brandts","year":"2020","journal-title":"Curr Opin Lipidol"},{"key":"R5-20260413","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management.","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"R6-20260413","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease.","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"R7-20260413","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"R8-20260413","doi-asserted-by":"crossref","first-page":"574474","DOI":"10.3389\/fgene.2020.574474","article-title":"Genetics of familial hypercholesterolemia: new insights.","volume":"11","author":"Vrablik","year":"2020","journal-title":"Front Genet"},{"key":"R9-20260413","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/gim.2017.151","article-title":"Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for FH diagnosis.","volume":"20","author":"Chora","year":"2018","journal-title":"Genet Med"},{"key":"R10-20260413","first-page":"527","article-title":"Legacy effect of short-term alirocumab in familial hypercholesterolaemia: a case report.","volume":"44","author":"Hamidi","year":"2022","journal-title":"Malays J Pathol"},{"key":"R11-20260413","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association.","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"R12-20260413","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5551\/jat.RV17050","article-title":"Homozygous familial hypercholesterolemia.","volume":"28","author":"Nohara","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"R13-20260413","first-page":"131","article-title":"Homozygous familial hypercholesterolemia.","volume":"36","author":"Alicezah","year":"2014","journal-title":"Malays J Pathol"},{"key":"R14-20260413","first-page":"87","article-title":"A successful pregnancy outcome of homozygous familial hypercholesterolaemia patient on statin therapy.","volume":"43","author":"Mohd Kasim","year":"2021","journal-title":"Malays J Pathol"},{"key":"R15-20260413","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0092-8674(76)90130-6","article-title":"Analysis of a mutant strain of human fibroblasts with a defect in the internalization of receptor-bound LDL.","volume":"9","author":"Brown","year":"1976","journal-title":"Cell"},{"key":"R16-20260413","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0092-8674(86)90533-7","article-title":"The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors.","volume":"45","author":"Davis","year":"1986","journal-title":"Cell"},{"key":"R17-20260413","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0092-8674(85)80054-4","article-title":"Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain.","volume":"41","author":"Lehrman","year":"1985","journal-title":"Cell"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:17:30Z","timestamp":1785784650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047768","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"2025-07-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}